Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 7, 2007

UCB Wins License from Lonza to GS Gene Expression System

  • Lonza granted UCB a nonexclusive, worldwide license to their GS Gene Expression System™ (GS: glutamine synthetase).

    The research evaluation agreement covers the use of the technology for R&D. An option to obtain a license to use the system for commercial purposes is included in the agreement.

    “We believe that having UCB select the GS Gene Expression System underscores the importance of this technology for the efficient production of therapeutic antibodies and recombinant proteins,” says Karen Fallen, commercial licensing manager at Lonza.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »